130 related articles for article (PubMed ID: 38332401)
1. Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.
Alp G; Oztas Y; Yalcinkaya A; Ozel S; Yildirim N; Unal S
Lipids; 2024 May; 59(3):75-82. PubMed ID: 38332401
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
Yildirim N; Unal S; Yalcinkaya A; Karahan F; Oztas Y
Ann Hematol; 2022 Jan; 101(1):35-41. PubMed ID: 34564750
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
4. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
6. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
Novelli EM; Kato GJ; Ragni MV; Zhang Y; Hildesheim ME; Nouraie M; Barge S; Meyer MP; Hassett AC; Gordeuk VR; Gladwin MT; Isenberg JS
Am J Hematol; 2012 Mar; 87(3):326-30. PubMed ID: 22318901
[TBL] [Abstract][Full Text] [Related]
7. Lactate dehydrogenase and hemolysis index to predict vaso-occlusive crisis in sickle cell disease.
Feugray G; Dumesnil C; Grall M; Benhamou Y; Girot H; Fettig J; Brunel V; Billoir P
Sci Rep; 2023 Dec; 13(1):21198. PubMed ID: 38040880
[TBL] [Abstract][Full Text] [Related]
8. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
9. The role of immature granulocyte percentage in predicting acute chest syndrome and the severity of the vaso-occlusive crisis in sickle cell disease.
Karahan F; Ünal S; Topçu DB; Öztaş Y; Bozlu G
Turk J Pediatr; 2022; 64(1):92-97. PubMed ID: 35286035
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
11. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity.
Li W; Pucka AQ; Debats C; Reyes BA; Syed F; O'Brien ARW; Mehta R; Manchanda N; Jacob SA; Hardesty BM; Greist A; Harte SE; Harris RE; Yu Q; Wang Y
Front Immunol; 2024; 15():1288187. PubMed ID: 38361924
[TBL] [Abstract][Full Text] [Related]
13. Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic Fibrosis.
Bal Topçu D; Tugcu G; Ozcan F; Aslan M; Yalcinkaya A; Polat SE; Hizal M; Yalcin EE; Ersoz DD; Ozcelik U; Kiper N; Lay I; Oztas Y
Lipids; 2020 May; 55(3):213-223. PubMed ID: 32120452
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.
Zakaria O; Buhalim RA; Almulhim F; Al Jabr FA; Alrashid A; Almutairi M
Cureus; 2021 May; 13(5):e14980. PubMed ID: 34123674
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A
Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544
[TBL] [Abstract][Full Text] [Related]
16. Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease.
Feugray G; Grall M; Dumesnil C; Brunel V; Benhamou Y; Quillard Muraine M; Billoir P
Lipids Health Dis; 2024 May; 23(1):140. PubMed ID: 38755670
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease.
Feugray G; Kasonga F; Grall M; Benhamou Y; Bobée-Schneider V; Buchonnet G; Daliphard S; Le Cam Duchez V; Lahary A; Billoir P
Front Med (Lausanne); 2022; 9():858911. PubMed ID: 35492334
[TBL] [Abstract][Full Text] [Related]
18. Changes in Blood Profile from Steady State in Patients with Sickle Cell Anemia Admitted for Vaso-occlusive Crisis and Acute Chest Syndrome.
Klouda T; Raybagkar D; Bernstein B; Apollonsky N
Adv Hematol; 2020; 2020():3656717. PubMed ID: 32908517
[TBL] [Abstract][Full Text] [Related]
19. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
[TBL] [Abstract][Full Text] [Related]
20. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
